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Question

Materials and Methods (cont.)

Results (cont.)

What natural coumarins show the best antiparasitic activity in Leishmania
and Trypanosoma parasites?

When each coumarin had been modeled, the same several tests were run on each
coumarin, computationally, using SPARTAN. The first test was to find the lowest energy
conformation of each coumarin. To find this, I used the “Equilibrium Conformer”
calculation, as well as using the “Molecular Mechanics” and “MMFF” settings, then run the
test. The second test was to find the optimized geometry for each coumarin. To find this, I
used the “Equilibrium Geometry” calculation, as well as using the “Semi-Empirical” and
“AM1” settings, then run the test while having the “QSAR,” “Orbitals & Energies,” and
“Charges & Bond Orders” settings all checked.
Once each coumarin had been modeled and tested in SPARTAN, I moved on to
docking each coumarin with several relevant protein targets, each a different protein in one
of the two types of parasites being studied. This docking process took place in a program
called Molegro Virtual Docker (MVD). First, each coumarin was uploaded to MVD and
converted to a ligand and prepared, which could then be placed in the cavities in the
proteins. Next, the protein target was loaded into MVD, and the docking process began.
Each of the 34 coumarins was docked with each cavity of the protein target, using 30 runs
per coumarin and using the “energy minimization” setting. Once the docking for each
cavity had been completed, MVD produced many results, the most relevant of which for us
was the “Rerank Score.” The highest Rerank Score for each coumarin for each cavity was
then documented in a separate spreadsheet.
The final part in the research was to be a QSAR analysis, which correlates electronic
structures with the activities of the molecule. Unfortunately I was not able to complete this
step in the research by this time.

When I looked at the Rerank Scores compiled in the spreadsheet,
several coumarins stood out to me. Of the 74 cavities total,
umbelliprenin had the highest Rerank Score for 36 of them. Mammea
A/AA had seven of the highest Rerank Scores, galbanic acid had six of
the highest, and auraptene had four of the highest. Mammea A/AA had
the highest score overall, with a score of -137.694 for cavity two of the
3kfl protein found in L. major, and umbelliprenin had the second and
third highest scores of -131.239 and -124.377, for cavity one of the 1e7w
protein found in L. major and cavity one of the 2oeg protein also found
in L. major, respectively.

Introduction
Parasitic infections, namely leishmaniasis and trypanosomiasis,
affect millions of people worldwide (WHO, 2012b). These two diseases hit
the poverty-stricken the hardest. Leishmaniasis is caused by the
leishmania parasite, and is found mainly in South America, the Middle
East, and Africa, where poverty is widespread (WHO, 2012a). Epidemics
of this disease have seriously impeded socioeconomic development in the
Amazon basin, Andean countries, Morocco, and Saudi Arabia (WHO,
2012a). American trypanosomiasis, also known as Chagas disease, is a
disease caused by the parasite Trypanosoma cruzi, and affects
approximately 10 million people, mainly in Latin America (WHO, 2012b).
These diseases are both cured easily if treatment is administered soon
after the infection begins, but treatment can be expensive, and therefore
unavailable to most of the infected population. Coumarins are a class of
compounds which have been found, in many scholarly studies, to have
antiparasitic activities. Those antiparasitic coumarins which are found in
nature are especially important, as they would help reduce the cost of
treatment, thus allowing more people to be cured.
In order to find which coumarins would be best to use for the
treatment of these infections, the coumarins (ligands) are docked into
various protein targets and the Rerank Scores, among other data, are
reported by the Molegro Virtual Docker (MVD). The Rerank Score is a
unitless measurement which is an estimate of the strength of the
interaction between a ligand and a protein (Molegro, 2011). The larger the
negative value of the Rerank Score, the better the strength, or binding
affinity. With a larger binding affinity, a ligand will reside for a longer time
within the protein, and cause a biological response within the protein,
which in this case, will hopefully be to cure the infected person of the
infection. Therefore, during this research, the ligands, or coumarins, with
the highest Rerank Scores will be those most closely examined, as they
will most likely be the best compounds for curing parasitic infections.

Materials and Methods
To begin this research, first I began by looking up scholarly articles
online using the keywords “coumarins and Leishmania” or “coumarins
and Trypanosoma.” After skimming through many articles, several were
downloaded and examined more thoroughly for the antiparasitic
information detailed within. Only coumarins which came from natural
sources and which had experimental antiparasitic activities, whether IC50,
LD50, EC50, or MC100 values with respect to each parasite, were
documented in a Microsoft Excel spreadsheet. Once all articles were
completely examined, 34 coumarins in total were documented in the
spreadsheet.
After the spreadsheet was created, each coumarin was modeled in
the SPARTAN computational chemistry software using the tools in it.
Care was taken to ensure that the correct stereochemistry was modeled,
as incorrect stereochemistry could lead to inaccurate results.

Results

Conclusion
The results show that the in silico tests back up the scholarly
experiments in many cases, such as umbelliprenin and auraptene.
Umbelliprenin had the highest Rerank Score for almost half of the
protein cavities, which means that its binding affinity is high for many
proteins. Due to its high binding affinity, it has a longer residence time
in the protein, which can produce a biological response that causes the
disease caused by the parasite to be cured. By using the coumarins that
produced the greatest Rerank Scores for each respective protein,
antidotes can be created to fight parasitic infections. Since all of the
coumarins found in the scholarly articles originated from natural
sources, not in a laboratory, these antidotes can be created at a lower
cost, and can benefit those who need it most, the poor, those without
proper nutrition, and those without well-built homes. With further
research, including the QSAR analysis, hopefully more can be learned
about curing these deadly diseases.

Acknowledgements
Figure 1. Image of (-) mammea A/BB, one
of the coumarins examined, modeled
using the SPARTAN software. Black
spheres indicate carbon atoms, red
spheres indicate oxygen atoms, and white
spheres indicate hydrogen atoms. All
coumarins were modeled similarly.

Figure 2. Image of 1a7k protein, found in L.
mexicana, as shown in MVD. The green area
indicates a cavity where ligands, i.e.
coumarins, would be docked. Proteins had
anywhere from one to three cavities.

Figures 1 and 2 show images of what a typical modeled coumarin and a protein
target would look like in SPARTAN and MVD, respectively.
Of the 34 coumarins and their respective antiparasitic activities found in the scholarly
articles, (-) mammea A/BB was the most effective, with an IC50 value of 0.88 μg/mL for the
L. amazonensis amastigote. Auraptene, umbelliprenin, and cycloisobrachycoumarinone
epoxide were also very effective against various parasites, with IC50 values of 5.10, 4.90, and
4.59 μg/mL, respectively. Among the least effective of these was coumarin, with an IC50
value of 100.11 μg/mL against the T. cruzi trypomastigote.
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